CJC-1295 (DAC Modification)
DAC-modified GHRH analog peptide.
Endocrine & Cell Signaling Research Peptides
Vesugen (KED) is a synthetic tripeptide (Lys-Glu-Asp). It is supplied for qualified laboratory research, analytical evaluation, and method-development purposes.
The source monograph flags an alternate CAS (70280-31-4) circulating for this product that it could not authoritatively verify against the KED sequence; 204271-66-9 is presented as the more widely recognized value. Confirm against the supplier's COA before quoting.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
DAC-modified GHRH analog peptide.
GHRH(1-29) amide peptide.
N-terminally hexenoylated GHRH(1-44) analog.